We are a clinical research group which runs alongside NHS services at Newquay Health Centre.
We work with the pharmaceutical industry to offer clinical trials that evaluate new and exciting medical treatments.
A study to evaluate the effect of triple medication inhalers in protecting patients from heart attacks and strokes in the long term
A trial of the effect of a new generation GLP1-agonist called retatrutide. This medication is the next generation version of Ozempic and Mounjaro. It is aimed only at people with exisiting or previous heart and kidney conditions who are living with obesity.
A trial to assess the benefits of Atogepant in patients with recurrent Migraines, who are unable to take, or have an intolerance to multiple triptans.
An exciting blood pressure medication called Zilebesiran which needs one injection every six months as an add-on therapy for people with uncontrolled/treatment resistant high blood pressure
A trial of lorundrostat, an exciting blood pressure medication, to treat uncontrolled/treatment resistant high blood pressure
A study to evaluate atogepant, a new generation medication, for the treatment of migraine
A new injectable medication for lowering triglycerides (fats) in the blood
A long term trial to find out whether inclisiran, a recently licensed injectable cholesterol medication, can prevent heart attacks and strokes in people with high cholesterol.
A study to evaluate the long-term safety and efficacy of LIB003, a new generation cholesterol lowering medication, in protecting patients from heart attacks and strokes
A trial looking at a fish oil from herring roe as a treatment for mild to moderate psoriasis
A dose finding trial to determine if Balcinrenone/Dapagliflozin is superior to Dapagliflozin in reducing albuminuria and to evaluate safety and tolerability.
An exciting new trial to evaluate the effect of cannabis extract in patients with chronic low back pain
A diabetes study examining the the benefit of LY3457263 (injection) in patients with Type 2 Diabetes currently on stable Semaglutide or Tirzepatide who failed to achieve their target HbA1c goal
A trial to evaluate whether treatment with Plozasiran compared to placebo can reduce the rigk to heart attacks or strokes in high risk patients.
A very exciting study assessing the efficacy and safety of Cagrilintide for weight management in overweight/obese patients with or without Diabetes.
A trial assessing the effect of a new medication on elevated Triglycerides and Remnant Cholesterol
Monday - Friday: 8:00am - 6:00pm
Saturday - Sunday: Closed